ÆéƼµå Ä¡·áÁ¦ ½ÃÀå º¸°í¼­ : À¯Çüº°, Á¦Á¶¾÷üº°, ÇÕ¼º ±â¼úº°, Åõ¿© °æ·Îº°, ¿ëµµº°, Áö¿ªº°(2024-2032³â)
Peptide Therapeutics Market Report by Type, Type of Manufacturer, Synthesis Technology, Routes of Administration, Application, and Region 2024-2032
»óǰÄÚµå : 1561423
¸®¼­Ä¡»ç : IMARC Group
¹ßÇàÀÏ : 2024³â 09¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 138 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 2,999 £Ü 4,339,000
PDF & Excel (Single User License) help
PDF, Excel º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â 1ȸ °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 3,999 £Ü 5,786,000
PDF & Excel (5 User License) help
PDF, Excel º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 4,999 £Ü 7,233,000
PDF & Excel (Corporate License) help
PDF, Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¼¼°èÀÇ ÆéƼµå Ä¡·áÁ¦ ½ÃÀå ½ÃÀå ±Ô¸ð´Â 2023³â¿¡ 428¾ï ´Þ·¯¿¡ ´ÞÇß½À´Ï´Ù. ÇâÈÄ IMARC GroupÀº ½ÃÀåÀÌ 2032³â±îÁö 869¾ï ´Þ·¯¿¡ ´ÞÇϸç, 2024-2032³â 7.9%ÀÇ ¼ºÀå·ü(CAGR)À» º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøÇϰí ÀÖ½À´Ï´Ù.

ÆéƼµå´Â À̿ ä³ÎÀ̳ª G´Ü¹éÁú °áÇÕÇü ¼ö¿ëü(GPCR)¿Í °°Àº ƯÁ¤ ¼¼Æ÷ Ç¥¸é ¼ö¿ëü¿¡ °áÇÕÇÏ¿© ¼¼Æ÷³» ÀÛ¿ëÀ» À¯¹ßÇÏ´Â È¿À²ÀûÀÌ°í ¼±ÅÃÀûÀÎ ½ÅÈ£Àü´Þ ºÐÀÚÀÔ´Ï´Ù. Á¦¾à¾÷°è¿¡¼­´Â ´Ù¾çÇÑ ¼¼Æ÷¸¦ Ç¥ÀûÀ¸·Î »ï°í ±× ¹ÝÀÀÀ» Á¶ÀÛÇÒ ¼ö ÀÖ´Â »õ·Î¿î Àç»ý Ä¡·áÁ¦¸¦ ¼³°èÇÏ´Â µ¥ Ȱ¿ëµÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Ä¡·áÁ¦´Â ´Ù¸¥ Ä¡·á¹ýº¸´Ù µ¶¼ºÀÌ ³·°í »ó´ëÀûÀ¸·Î ¾ÈÀüÇÏ¸ç ³»¾à¼ºÀÌ ¿ì¼öÇÕ´Ï´Ù. ±× °á°ú, ¾Ï, ºÎ»ó, °¨¿°, ´ë»çÀÌ»ó, ¹Ì¿ë ¹®Á¦¸¦ °ü¸®Çϱâ À§ÇØ Àü ¼¼°è ÀÓ»ó ÇöÀå¿¡¼­ ¼±È£µÇ°í ÀÖ½À´Ï´Ù.

ÆéƼµå Ä¡·áÁ¦ ½ÃÀå µ¿Çâ :

±Þ¼º ¹× ¸¸¼ºÁúȯÀÇ À¯º´·ü Áõ°¡¿Í ÀÇ·á ½Ã¼³¿¡ ´ëÇÑ Á¢±Ù¼º Çâ»óÀº Çõ½ÅÀûÀÎ Ä¡·á¹ýÀ» °³¹ßÇϱâ À§ÇÑ ÆéƼµå ¼ö¿ä¿¡ ±àÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÄ¡´Â ÁÖ¿ä ¿äÀÎ Áß ÇϳªÀÔ´Ï´Ù. ¶ÇÇÑ ÆéƼµå Ä¡·á´Â ÇǺΠ³ëÈ­ °úÁ¤À» ´ÊÃß±â À§ÇØ ¹Ì¿ë ¼ö¼ú¿¡ »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. ÀÌ´Â °³ÀÎÀÇ ¿Ü¸ð¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö°í Àþ°í °Ç°­ÇÑ ÇǺθ¦ À¯ÁöÇÏ·Á´Â ¿å±¸¿Í ÇÔ²² Àü ¼¼°è¿¡¼­ ¹Ì¿ë ¼ö¼ú ¹× ÆéƼµå Ä¡·áÁ¦ÀÇ Ã¤ÅÃÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. À̿ʹ º°µµ·Î, ÆéƼµå Ä¡·áÁ¦´Â ÁÖ»ç Ƚ¼ö¸¦ ÁÙÀÌ°í ¾ÈÁ¤¼º ¹× ±âŸ ¹°¸®Àû Ư¼ºÀ» °³¼±ÇÏ´Â »õ·Î¿î ÇÕ¼º Àü·«ÀÇ µµÀÔÀ¸·Î ÀÎÇØ ´ç´¢º´ ȯÀÚ¿¡°Ô ÁÖ»çÇÏ´Â µ¥ ³Î¸® »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. ÀÌ´Â ´ç´¢º´ À¯º´·ü Áõ°¡¿Í ½Å¼ÓÇϰí Á¤È®ÇÑ Ä¡·á¹ý¿¡ ´ëÇÑ ¼±È£µµ Áõ°¡¿Í ÇÔ²² °æ±¸¿ë ¾à¹°º¸´Ù ÆéƼµå Ä¡·áÁ¦ÀÇ »ç¿ë¿¡ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ °³ÀÎ ¸ÂÃãÇü Ä¡·á¿Í Ç¥Àû Ä¡·áÀÇ »õ·Î¿î µ¿ÇâÀº ´Ù±â´É ÆéƼµå ±â¹Ý ¹°Áú¿¡ ´ëÇÑ ¼ö¿ä¸¦ ºÒ·¯ÀÏÀ¸Å°°í ÀÖ½À´Ï´Ù. ¿©±â¿¡ ÀÚ°¡¸é¿ªÁúȯ ¹× ¿°Áõ¼º ÁúȯÀ» Ä¡·áÇϱâ À§ÇÑ ½Å±Ô ÆéƼµå Ä¡·áÁ¦ °³¹ßÀ» À§ÇÑ ÀÚ±ÝÀÌ Áõ°¡Çϰí ÀÖÀ¸¸ç, ½ÃÀå Àü¸ÁÀº ¹àÀ» °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÀÌ º¸°í¼­¿¡¼­ ´Ù·é ÁÖ¿ä Áú¹®

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹üÀ§¿Í Á¶»ç ¹æ¹ý

Á¦3Àå °³¿ä

Á¦4Àå ¼­·Ð

Á¦5Àå ¼¼°èÀÇ ÆéƼµå Ä¡·áÁ¦ ½ÃÀå

Á¦6Àå ½ÃÀå ³»¿ª : À¯Çüº°

Á¦7Àå ½ÃÀå ³»¿ª : Á¦Á¶¾÷üº°

Á¦8Àå ½ÃÀå ³»¿ª : ÇÕ¼º ±â¼úº°

Á¦9Àå ½ÃÀå ³»¿ª : Åõ¿© °æ·Îº°

Á¦10Àå ½ÃÀå ³»¿ª : ¿ëµµº°

Á¦11Àå ½ÃÀå ³»¿ª : Áö¿ªº°

Á¦12Àå SWOT ºÐ¼®

Á¦13Àå ¹ë·ùüÀÎ ºÐ¼®

Á¦14Àå Porter's Five Forces ºÐ¼®

Á¦15Àå °¡°Ý ºÐ¼®

Á¦16Àå °æÀï ±¸µµ

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The global peptide therapeutics market size reached US$ 42.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 86.9 Billion by 2032, exhibiting a growth rate (CAGR) of 7.9% during 2024-2032.

Peptides are efficacious and selective signaling molecules that bind to specific cell surface receptors, such as ion channels and G protein-coupled receptors (GPCRs) and trigger intracellular effects. They are employed in the pharmaceutical industry to design novel regenerative therapeutics that can target a wide range of cells and manipulate their responses. These therapeutics are less toxic, relatively safe, and well-tolerated than other treatment options. As a result, they are gaining traction in clinical practices worldwide to manage cancer, injuries, infectious diseases, metabolic disorders, and aesthetic concerns.

Peptide Therapeutics Market Trends:

The growing prevalence of acute and chronic diseases, along with the rising access to medical facilities, represents one of the leading factors positively influencing the demand for peptides to develop innovative therapies. Moreover, peptides therapies are used in cosmeceutical surgeries to slow down the process of skin aging. This, coupled with the increasing consciousness among individuals about physical appearance and the desire to retain young and healthy skin, is driving the adoption of cosmetic surgeries and peptide therapeutics around the world. Apart from this, with the introduction of novel synthetic strategies that reduce injection frequency and improve stability and other physical properties, peptide therapeutics are widely being used in injections for diabetic patients. This, in confluence with the increasing incidence of diabetes and the growing preference for quick and precise treatment methods, is influencing the use of peptide therapeutics over oral medications. Furthermore, the emerging trend of personalized and targeted treatments is catalyzing the demand for multifunctional peptide-based materials. This, along with the rising funding to develop novel peptide therapeutics for treating autoimmune and inflammatory diseases, is projected to create a positive market outlook.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global peptide therapeutics market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on type, type of manufacturer, synthesis technology, routes of administration and application.

Breakup by Type:

Breakup by Type of Manufacturer:

Breakup by Synthesis Technology:

Breakup by Routes of Administration:

Breakup by Application:

Breakup by Region:

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Amgen Inc., Apitope International NV, Arch Biopartners Inc., AstraZeneca plc, Circle Pharma Inc., Corden Pharma GmbH, F. Hoffmann-La Roche AG, Ipsen Group, Lonza Group AG, Novo Nordisk A/S, Pfizer Inc., Teva Pharmaceuticals Industries Ltd. and Zealand Pharma A/S.

Key Questions Answered in This Report

Table of Contents

1 Preface

2 Scope and Methodology

3 Executive Summary

4 Introduction

5 Global Peptide Therapeutics Market

6 Market Breakup by Type

7 Market Breakup by Type of Manufacturer

8 Market Breakup by Synthesis Technology

9 Market Breakup by Routes of Administration

10 Market Breakup by Application

11 Market Breakup by Region

12 SWOT Analysis

13 Value Chain Analysis

14 Porters Five Forces Analysis

15 Price Analysis

16 Competitive Landscape

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â